6-28227724-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_006299.5(ZSCAN9):c.455G>A(p.Cys152Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000148 in 1,608,958 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006299.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZSCAN9 | NM_006299.5 | c.455G>A | p.Cys152Tyr | missense_variant | 3/4 | ENST00000252207.10 | NP_006290.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZSCAN9 | ENST00000252207.10 | c.455G>A | p.Cys152Tyr | missense_variant | 3/4 | 1 | NM_006299.5 | ENSP00000252207 | P2 |
Frequencies
GnomAD3 genomes AF: 0.000138 AC: 21AN: 152208Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000130 AC: 32AN: 246410Hom.: 0 AF XY: 0.000173 AC XY: 23AN XY: 133320
GnomAD4 exome AF: 0.000149 AC: 217AN: 1456750Hom.: 1 Cov.: 31 AF XY: 0.000168 AC XY: 122AN XY: 724740
GnomAD4 genome AF: 0.000138 AC: 21AN: 152208Hom.: 0 Cov.: 32 AF XY: 0.0000807 AC XY: 6AN XY: 74364
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 17, 2022 | The c.455G>A (p.C152Y) alteration is located in exon 3 (coding exon 2) of the ZSCAN9 gene. This alteration results from a G to A substitution at nucleotide position 455, causing the cysteine (C) at amino acid position 152 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at